The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy

QR Code

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy

Immune restoration disease associated with Mycobacterium tuberculosis is a complication of antiretroviral therapy seen in a subset of HIV-1 patients soon after they commence antiretroviral therapy. It is characterized by a 'paradoxical' worsening of treated tuberculosis or an 'unmaski...

Full description

Bibliographic Details
Main Authors:	Oliver, B., Price, Patricia
Format:	Journal Article
Published:	2011
Online Access:	http://hdl.handle.net/20.500.11937/28736

Similar Items

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Polymorphisms in IL10 may alter CD4 T-cell counts in Indonesian HIV patients beginning antiretroviral therapy
by: Dmello, D., et al.
Published: (2017)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome
by: French, M., et al.
Published: (2011)

Immunological determinants of tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in HIV-infected patients on antiretroviral therapy / Tan Hong Yien
by: Tan, Hong Yien
Published: (2016)

Mycobacterial immune restoration disease: One symphony, two or many?
by: Price, Patricia
Published: (2012)

Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
by: Goh, Kian Guan, et al.
Published: (2017)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
by: Sumatoh, H., et al.
Published: (2011)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Ethnicity as predictor of immune reconstitution among Malaysian HIV‐positive patients treated with highly active antiretroviral therapy
by: Mohamad Isa, Irma Izani, et al.
Published: (2020)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)

Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection
by: Chukwuanukwu, Rebecca C., et al.
Published: (2016)

Immune restoration diseases reflect diverse immunopathological mechanisms
by: Price, Patricia, et al.
Published: (2009)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease
by: Tan, D., et al.
Published: (2011)

Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
by: Crane, M., et al.
Published: (2009)

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Hearps, A., et al.
Published: (2017)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens
by: Oliver, B., et al.
Published: (2012)

The role of human herpesvirus (HHV) infections and persistent immune activation in antiretroviral therapy-treated HIV infected individuals / Yap Siew Hwei
by: Yap, Siew Hwei
Published: (2018)

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation
by: Agarwal, U., et al.
Published: (2012)

Reply to 'TLR-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells'
by: Tan, D., et al.
Published: (2012)

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease
by: Lim, A., et al.
Published: (2008)

Kepatuhan pesakit HIV positif terhadap rawatan Highly Active Antiretroviral Therapy (HAART)
by: Najwa Afiqa Roshaizad,, et al.
Published: (2020)

Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
by: Hejazi, Nazisa, et al.
Published: (2010)

Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART
by: Karim, B., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7bdgk6dbb25m6jtebpn3mgulsn